Allarity Therapeutics, Inc. (ALLR) vs Vyome Holdings, Inc. (HIND)
A side-by-side comparison of Allarity Therapeutics, Inc. and Vyome Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLR
Allarity Therapeutics, Inc.
$1.00HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
HIND
Vyome Holdings, Inc.
$1.93HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALLR vs HIND
growth of $100 · dividends reinvested · last 5yALLR -100.0% (-95.9%/yr)HIND -100.0% (-92.6%/yr)HIND compounded faster over this window
Log scale — wide-divergence pair
ALLR HIND
ALLR vs HIND: by the numbers
- •ALLR is the larger company ($16M vs $14M market cap).
- •Both run net losses; ALLR's is the smaller (-3575.07% vs -8716.77% net margin).
Metrics side by side
Valuation
| Metric | ALLR | HIND |
|---|---|---|
| P/S ratio | 46.12 | 104.42 |
| P/B ratio | 4.50 | 2.24 |
| FCF yield | N/A | 3.87% |
Profitability
| Metric | ALLR | HIND |
|---|---|---|
| Gross margin | 107.54% | 64.68% |
| Operating margin | -3939.06% | -859.22% |
| Net margin | -3575.07% | -8716.77% |
| ROE | -348.81% | -186.95% |
| ROIC | -41.81% | -57.53% |
Growth (annualized)
| Metric | ALLR | HIND |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -60.54% |
| Total return CAGR (5Y) | N/A | -92.93% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.